4,194 results · 39ms · Sources: EU EUDAMED, US FDA

ViVi® Surgical Helmet System (ViVi® Helmet, ViVi® Helmet HPL, ViVi® Hood)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

ELCAM STOPCOCKS AND MANIFOLDS

FDA 510(k)
FDA Class 2 ·General Hospital

ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM PO

FDA 510(k)
FDA Class 2 ·Immunology

HASKAL TORQUE DEVICE

FDA 510(k)
FDA Class 2 ·Cardiovascular

ELIA M2; IMMUNOASSAY, POSITIVE CONTROL 100, POSITIVE CONTROL 250

FDA 510(k)
FDA Class 2 ·Immunology

ViVi® Toga Premium

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Codman Electrosurgical Generator, Foot Pedal

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Radioimmunoassay, Cyclic Amp

FDA classification
FDA Class 2 ·Radioimmunoassay, Cyclic Amp

Radioimmunoassay, Cyclic Gmp

FDA classification
FDA Class 2 ·Radioimmunoassay, Cyclic Gmp

Ocular Pattern Recorder

FDA classification
FDA Class 2 ·Ocular Pattern Recorder

CARDIOSMART

FDA 510(k)
FDA Class 2 ·Cardiovascular

CARDIO SERV

FDA 510(k)
FDA Class 2 ·Cardiovascular

Attachment, Intermittent Mandatory Ventilation (Imv)

FDA classification
FDA Class 2 ·Attachment, Intermittent Mandatory Ventilation (Imv)

Test, Albumin Cobalt Binding

FDA classification
FDA Class 2 ·Test, Albumin Cobalt Binding

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·Elecsys free PSA Test System

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·Elecsys free PSA Test System

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·Elecsys free PSA

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·Dimension TPSA Flex reagent cartridge (RF451)

Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

FDA Pre-Market Approval
FDA Class 2 ·CA 125 ANTIBODY RIA

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·IMMULITE/IMMULITE 1000 PSA & 1000 THIRD GENERATION PSA